The follow-up webinar “Role of in vitro and in silico methodologies in COVID-19 research” held Monday, January 18, 2021, has been uploaded online to the EUROTOX WEB
The webinar is organised In2TOX specialty section of EUROTOX via Zoom platform and is limited to 100 persons. ESTIV is an affiliated society to EUROTOX. Registration is free but mandatory.
To register, please submit the form at https://forms.gle/gRN9wV2ighFLc157A
The first 100 registrants will receive a Zoom invitation prior to the meeting.
|“Role of in vitro and in silico methodologies in COVID-19 research” scheduled Monday, January 18, 2021 from 13h00 to 14h00 CET. This webinar is a repeat and update of the webinar held September 17, 2020. The program includes two presentations and Q&A discussion.|
13h00 Introduction: Prof. Mathieu Vinken, Chair In2TOX-EUROTOX
13h05 “New approach methods as door-openers for drugs and vaccines or the other way around?” Prof. Thomas Hartung, Center for Alternatives to Animal testing, Johns Hopkins University Bloomberg School of Public Health-USA
13h25 “Studying the interaction between coronavirus spike protein and human target receptors using 3D in silico modelling: could anthraquinone compounds prevent the interaction?” Dr. Luca Dellafiora, Department of Food and Drug, University of Parma-Italy
13h45 Q&A: Prof. Mathieu Vinken, Chair In2TOX-EUROTOX
About IN2TOX – IN VITRO AND IN SILICO TOXICOLOGY SPECIALTY SECTION
The first In2Tox meeting establishing the speciality section was held Monday, September 9, 2019 during the 2019 EUROTOX Helsinki congress. The objectives of In2TOX SS are:
- To serve as a focal point for interaction of members of EUROTOX interested in the field of in vitro and in silico toxicology.
- To propose scientific programs, such as workshops and symposia, to be held at EUROTOX annual congresses, and to promote educational activities that emphasize developments in fundamental and applied in vitro and in silico toxicology.
- To relate those developments to the activities of EUROTOX in order to stimulate growth in the science of in vitro methods, in silico modelling and new approach methodologies in general.
- Mathieu Vinken: Chair
- Jean-Lou Dorne: Secretary
- Helena Kandarova: Communications
- Nynke Kramer: Relations Specialty Sections and other Societies